Current Pharmaceutical Design
Title: Preface
Volume: 8 Issue: 17
Author(s): Salvatore Guccione
Affiliation:
Export Options
About this article
Cite this article as:
Guccione Salvatore, Preface, Current Pharmaceutical Design 2002; 8 (17) . https://dx.doi.org/10.2174/1381612023394296
DOI https://dx.doi.org/10.2174/1381612023394296 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Ovulation Induction in Anovulatory Patients with Polycystic Ovary Syndrome
Current Drug Therapy The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimers Disease: From Model Organisms to Human Disease
Current Alzheimer Research Recent Progress on Apoptotic Activity of Triazoles
Current Drug Targets Design of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: A History Driven by Biology to Chemistry
Medicinal Chemistry Ultrasound and Microbubble Guided Drug Delivery: Mechanistic Understanding and Clinical Implications
Current Pharmaceutical Biotechnology Cucurbitacins and the Immune System: Update in Research on Anti- inflammatory, Antioxidant, and Immunomodulatory Mechanisms
Current Medicinal Chemistry Structure-Function Relationships of Plasminogen Activator Inhibitor-1 and Its Potential as a Therapeutic Agent
Current Drug Targets Mast Cells as a Double-Edged Sword in Immunity: Their Function in Health and Disease. First of Two Parts
Endocrine, Metabolic & Immune Disorders - Drug Targets Sigma-2 Receptor as a Potential Drug Target
Current Medicinal Chemistry Insulin Resistance and Alzheimers Disease Pathogenesis: Potential Mechanisms and Implications for Treatment
Current Alzheimer Research Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review
Current Drug Metabolism Pulse Wave Velocity Assessment for Cardiovascular Risk Prognostication in ESKD: Weighting Recent Evidence
Current Vascular Pharmacology Melanocortins and their Receptors and Antagonists
Current Drug Targets Effects of Pregnancy-induced Insulin Resistance on the Fetus and the Future Development of Metabolic Diseases in Adulthood
Current Vascular Pharmacology Nanosuspension: A Potential Nanoformulation for Improved Delivery of Poorly Bioavailable Drug
Micro and Nanosystems Oral Delivery of Antidiabetic Polypeptide-k: Journey so far and the Road Ahead
Current Drug Delivery Survival Benefits of N-Acetylcysteine in Rodenticide Poisoning: Retrospective Evidence from an Indian Tertiary Care Setting
Current Reviews in Clinical and Experimental Pharmacology “Connecting the Dots” from Blood Brain Barrier Dysfunction to Neuroinflammation and Alzheimer’s Disease
Current Neurovascular Research Theranostic Aspects: Treatment of Cancer by Nanotechnology
Mini-Reviews in Medicinal Chemistry